Development of screening assays for nanoparticle toxicity assessment in human blood: preliminary studies with charged Au nanoparticles.

Nanomedicine (Lond)

Department of Chemistry, University of Minnesota, Kolthoff & Smith Halls, 207 Pleasant Street SE, Minneapolis, MN 55455, USA.

Published: September 2012

As nanoparticles have found increased use in both consumer and medical applications, corresponding increases in possible exposure to humans necessitate studies examining the impacts of these nanomaterials in biological systems. This article examines the effects of approximately 30-nm-diameter gold nanoparticles, with positively and negatively charged surface coatings in human blood. Here, we study the exposure effects, with up to 72 h of exposure to 5, 15, 25 and 50 µg/ml nanoparticles on hemolysis, reactive oxygen species (ROS) generation and platelet aggregation in subsets of cells from human blood. Assessing viability with hemolysis, results show significant changes in a concentration-dependent fashion. Rates of ROS generation were investigated using the dichlorofluorscein diacetate-based assay as ROS generation is a commonly suspected mechanism of nanoparticle toxicity; herein, ROS was not a significant factor. Optical monitoring of platelet aggregation revealed that none of the examined nanoparticles induced aggregation upon short-term exposure.

Download full-text PDF

Source
http://dx.doi.org/10.2217/nnm.12.17DOI Listing

Publication Analysis

Top Keywords

human blood
12
ros generation
12
nanoparticle toxicity
8
platelet aggregation
8
nanoparticles
5
development screening
4
screening assays
4
assays nanoparticle
4
toxicity assessment
4
assessment human
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!